nicotine patch

Study explores nicotine patch to treat late-life depression

Backed by nearly $5 million in funding, researchers from Vanderbilt University Medical Center are testing to see whether transdermal nicotine patches can improve mood, forgetfulness and attentiveness in adults over 60 with a diagnosis of depression.

Nicotine patch shows promise in treating late-life depression

A Vanderbilt University Medical Center pilot study of treating late-life depression in nonsmokers with transdermal nicotine (nicotine patch) has yielded some promising results, but the study’s author cautions that more study is needed.

Smoking study personalizes treatment

A simple blood test is allowing Vanderbilt University Medical Center (VUMC) researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.

elderly man lost in thought and looking out window in home office

Study explores nicotine patch to treat mild cognitive impairment

Three years ago Reece Dean, of Nashville’s Bellevue community, retired at age 69 from a career as a busy truck driver. Mary Ann, his wife, began to notice some changes in his memory and behavior since he was home more consistently.